Editorial Board Member - JBBS
Dr. Robert R. Redfield is currently working as a professor and as IHV Associate Director and Director of the Division of Clinical Care and Research, at University of Maryland, Baltimore. He received many honors and awards in his career. He published many articles in international journals.
Dr. Robert R. Redfield research is mainly focused on clinical research and clinical care of chronic human viral infections, especially HIV. His dominant area of research interest is the development of novel biological approaches to the treatment of chronic viral pathogens with a particular focus of targeting host cell pathways for their therapeutic potential. Several novel areas under active translation investigation include: targeting key biochemical pathways of nucleotide biosynthesis to enhance activity of specific antiretroviral medication; targeting cell activation with specific cell cycles as aprimary treatment target; use of G1 cell cycle agents to down regulate expression of key HIV host cell receptors; use of G1 cell cycles to enhance antiviral activity of HIV entry inhibitors; and the use of HIV specific proteins as therapeutic vaccines.
Other Editorial Board Members - JBBS
Departments of Pathology and Neurology
Case Western Reserve University School of Medicine
Department of Microbiology and Infectious Diseases
University of Buenos Aires
Department of Microbiology and Immunology
National Cheng Kung University
Department of Biomedical Engineering
Arizona Veterinary Diagnostic Laboratory
University of Arizona
Department of Pathology
State Key Laboratory of Food Science and Technology
University of Rhode Island